81 related articles for article (PubMed ID: 24059991)
1. [The effects of failure of low density lipoprotein receptor expression induced by inflammation on radial artery foam cell formation in patients with end-stage renal disease].
Ma KL; Liu J; Gao M; Ni J; Zhang Y; Zhang XL; Liu H; Huang HQ; Chen L; Wang YL; Liu BC
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):464-8. PubMed ID: 24059991
[TBL] [Abstract][Full Text] [Related]
2. Activation of mTOR contributes to foam cell formation in the radial arteries of patients with end-stage renal disease.
Ma KL; Liu J; Gao M; Wang CX; Ni J; Zhang Y; Zhang XL; Liu H; Wang YL; Liu BC
Clin Nephrol; 2014 Jun; 81(6):396-404. PubMed ID: 24755105
[TBL] [Abstract][Full Text] [Related]
3. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
4. Inflammation disrupts the LDL receptor pathway and accelerates the progression of vascular calcification in ESRD patients.
Liu J; Ma KL; Gao M; Wang CX; Ni J; Zhang Y; Zhang XL; Liu H; Wang YL; Liu BC
PLoS One; 2012; 7(10):e47217. PubMed ID: 23115640
[TBL] [Abstract][Full Text] [Related]
5. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
[No Abstract] [Full Text] [Related]
6. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice.
Xu ZE; Chen Y; Huang A; Varghese Z; Moorhead JF; Yan F; Powis SH; Li Q; Ruan XZ
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F713-22. PubMed ID: 21795641
[TBL] [Abstract][Full Text] [Related]
8. Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease.
Liu J; Ma KL; Zhang Y; Wu Y; Hu ZB; Lv LL; Tang RN; Liu H; Ruan XZ; Liu BC
Int J Biochem Cell Biol; 2015 Apr; 61():8-19. PubMed ID: 25622557
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro.
Yuan Y; Zhao L; Chen Y; Moorhead JF; Varghese Z; Powis SH; Minogue S; Sun Z; Ruan XZ
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F236-43. PubMed ID: 21511699
[TBL] [Abstract][Full Text] [Related]
11. [Inflammation enhances the accumulation of lipid in ApoE/SRA/CD36 KO mice liver].
Yan F; Huang AL; Xu ZE; Ruan XZ; Chen YX
Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):366-70. PubMed ID: 20510003
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease.
Ma KL; Gong TK; Hu ZB; Zhang Y; Wang GH; Liu L; Chen PP; Lu J; Lu CC; Liu BC
BMC Nephrol; 2018 Aug; 19(1):192. PubMed ID: 30071823
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between TLR4-MyD88-NF-κB and SCAP-SREBP2 pathways mediates macrophage foam cell formation.
Li LC; Varghese Z; Moorhead JF; Lee CT; Chen JB; Ruan XZ
Am J Physiol Heart Circ Physiol; 2013 Mar; 304(6):H874-84. PubMed ID: 23335792
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines.
Ruan XZ; Moorhead JF; Tao JL; Ma KL; Wheeler DC; Powis SH; Varghese Z
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1150-5. PubMed ID: 16543490
[TBL] [Abstract][Full Text] [Related]
16. Enhanced SCAP glycosylation by inflammation induces macrophage foam cell formation.
Zhou C; Lei H; Chen Y; Liu Q; Li LC; Moorhead JF; Varghese Z; Ruan XZ
PLoS One; 2013; 8(10):e75650. PubMed ID: 24146768
[TBL] [Abstract][Full Text] [Related]
17. Difference in LDL receptor feedback regulation in macrophages and vascular smooth muscle cells: foam cell transformation under inflammatory stress.
Ye Q; Lei H; Fan Z; Zheng W; Zheng S
Inflammation; 2014 Apr; 37(2):555-65. PubMed ID: 24297394
[TBL] [Abstract][Full Text] [Related]
18. Activation of the mTORC1 pathway by inflammation contributes to vascular calcification in patients with end-stage renal disease.
Liu J; Zhu W; Jiang CM; Feng Y; Xia YY; Zhang QY; Zhang M
J Nephrol; 2019 Feb; 32(1):101-110. PubMed ID: 29761287
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins.
Dong W; Wang X; Bi S; Pan Z; Liu S; Yu H; Lu H; Lin X; Wang X; Ma T; Zhang W
Int J Mol Med; 2014 May; 33(5):1161-8. PubMed ID: 24584901
[TBL] [Abstract][Full Text] [Related]
20. Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis.
Ma KL; Ni J; Wang CX; Liu J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Int J Med Sci; 2013; 10(12):1615-24. PubMed ID: 24151433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
